who should not take retatrutide isn't magic. Yes, the data is impressive. The mechanism is powerful. And for the right patient, under real medical oversight, this class of medications can meaningfully improve metabolic risk. But rapid Who Should Not Take Retatrutide?
Description
Neuroscience
The administration of the triple agonist resulted in the improvement of steatohepatitis in a dose-dependent fashion, with some female mice showing a complete resolution
GLP-1 medications can amplify the blood sugar lowering effects of these drugs, creating hypoglycemia risk that needs careful monitoring, especially during the initial dose titration weeks
TRIUMPH-1 results announced May 2026 represent the first pivotal Phase 3 data
Thyroid function testing (TSH, free T4) should be current before attributing treatment failure solely to the injection
